Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / vertex s cystic fibrosis drug gets fda priority revi

VRTX - Vertex's cystic fibrosis drug gets FDA priority review

Vertex Pharmaceuticals Incorporated

2024-07-02 08:58:53 ET

Vertex Pharmaceuticals ( NASDAQ: VRTX ) has been granted FDA priority review for its investigational once-daily vanza triple combination treatment for cystic fibrosis, with a target action date set for January 2, 2025....

For further details see:

Vertex’s cystic fibrosis drug gets FDA priority review
Stock Information
Company Name: Vertex Pharmaceuticals Incorporated
Stock Symbol: VRTX
Market: NASDAQ
Website: vrtx.com
Menu
VRTX VRTX Quote VRTX Short VRTX News VRTX Articles VRTX Message Board
Get VRTX Alerts

News, Short Squeeze, Breakout and More Instantly...